-+ 0.00%
-+ 0.00%
-+ 0.00%

Mustang Bio Inc. Secures FDA Orphan Drug Designation for MB-101 to Treat Astrocytomas and Glioblastoma

Reuters·07/09/2025 10:01:39

Please log in to view news